CLINICAL_TRIALS
trial_result
· 2011-06-06
Clinical Trial Update: Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer [Phase 1]
Summary
Phase 1 study assessing liposome-encapsulated mitoxantrone (LEM) in patients with advanced cancer has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: INSYS Therapeutics Inc | Conditions: Tumors | Phase 1 | Status: COMPLETED